- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 318464, 5 pages
Changes in Maternal Serum Transforming Growth Factor Beta-1 during Pregnancy: A Cross-Sectional Study
1Women’s Hospital, Kensington Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK
2University of Port Harcourt Teaching Hospital, Rivers State, P.M.B 6713, Nigeria
3Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, Robert Kilpatrick Clinical Sciences Building, University of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK
Received 13 July 2013; Revised 13 September 2013; Accepted 18 September 2013
Academic Editor: Egle Bytautiene
Copyright © 2013 Mandeep Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- N. Chegini, J. Simms, R. S. Williams, and B. J. Masterson, “Identification of epidermal growth factor, transforming growth factor-α, and epidermal growth factor receptor in surgically induced pelvic adhesions in the rat and intraperitoneal adhesions in the human,” American Journal of Obstetrics and Gynecology, vol. 171, no. 2, pp. 321–328, 1994.
- P. Rotwein, “Structure, evolution, expression and regulation of insulin-like growth factors I and II,” Growth Factors, vol. 5, no. 1, pp. 3–18, 1991.
- S. Sadek, T. G. Unterman, and S. C. Bell, “Epithelial localization of insulin-like growth factor binding protein 1 in the uterus of the rat during pregnancy, deciduoma-bearing pseudopregnancy and hormone treatment,” Journal of Reproduction and Fertility, vol. 101, no. 1, pp. 67–75, 1994.
- R. Gabriel, E. Alsat, and D. Evain-Brion, “Alteration of epidermal growth factor receptor in placental membranes of smokers: relationship with intrauterine growth retardation,” American Journal of Obstetrics and Gynecology, vol. 170, no. 5 I, pp. 1238–1243, 1994.
- Y. Fujita, H. Kurachi, K. Morishige et al., “Decrease in epidermal growth factor receptor and its messenger ribonucleic acid levels in intrauterine growth-retarded and diabetes mellitus-complicated pregnancies,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 6, pp. 1340–1345, 1991.
- P. A. Gruppuso, T. R. Curran, J. E. Mead, N. Fausto, and W. Oh, “Fetal growth factors as determinants of intrauterine hepatic growth,” Diabetes, vol. 40, supplement 2, pp. 51–55, 1991.
- C. H. Graham, J. J. Lysiak, K. R. McCrae, and P. K. Lala, “Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation,” Biology of Reproduction, vol. 46, no. 4, pp. 561–572, 1992.
- P. M. Rowe, “Clinical potential for TGF-β,” The Lancet, vol. 344, no. 8915, pp. 72–73, 1994.
- P. Murthi, T. Gunatilake, S. Chua et al., “Increased expression of homeobox gene TGIF-1 contributes to aberrant feto-placental angiogenesis in human idio-pathic fetal growth restriction,” submitted to. Placenta.
- M. Hernandez-Valencia, A. Zarate, R. Ochoa, M. E. Fonseca, D. Amato, and M. De Jesus Ortiz, “Insulin-like growth factor I, epidermal growth factor and transforming growth factor beta expression and their association with intrauterine fetal growth retardation, such as development during human pregnancy,” Diabetes, Obesity and Metabolism, vol. 3, no. 6, pp. 457–462, 2001.
- D. Briana, S. Liosi, D. Gourgiotis et al., “Fetal concentrations of the growth factors TGF-a and TGF-b1 in relation to normal and restricted fetal growth at term,” Cytokine, vol. 60, pp. 157–161, 2012.
- A. Huber, L. Hefler, C. Tempfer, H. Zeisler, A. Lebrecht, and P. Husslein, “Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia,” Acta Obstetricia et Gynecologica Scandinavica, vol. 81, no. 2, pp. 168–171, 2002.
- M. Ayatollahi, A. S. Dehaghani, and Z. Tabei, “Maternal serum levels of Transforming Growth Factor ß1 (TGF-ß1) in normal andpreeclampticpregnancies,” International Journal of Immunology, vol. 2, pp. 50–55, 2005.
- F. Lyall, H. Simpson, J. N. Bulmer, A. Barber, and S. C. Robson, “Transforming growth factor-β expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction,” American Journal of Pathology, vol. 159, no. 5, pp. 1827–1838, 2001.
- M. A. Wilcox, I. R. Johnson, P. V. Maynard, S. J. Smith, and C. E. D. Chilvers, “The individualised birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone,” British Journal of Obstetrics and Gynaecology, vol. 100, no. 4, pp. 342–347, 1993.
- D. J. Grainger and J. C. Metcalfe, “A pivotal role for TGF-β in atherogenesis?” Biological Reviews of the Cambridge Philosophical Society, vol. 70, no. 4, pp. 571–596, 1995.
- T.-A. Dickens and A. A. Colletta, “The pharmacological manipulation of members of the transforming growth factor beta family in the chemoprevention of breast cancer,” BioEssays, vol. 15, no. 1, pp. 71–74, 1993.
- E. Jane Mitchell and M. D. O'Connor-McCourt, “A transforming growth factor β (TGF-β) receptor from human placenta exhibits a greater affinity for TGF-β2 than for TGF-β1,” Biochemistry, vol. 30, no. 17, pp. 4350–4356, 1991.
- C. H. Graham and P. K. Lala, “Mechanism of control of trophoblast invasion in situ,” Journal of Cellular Physiology, vol. 148, no. 2, pp. 228–234, 1991.
- J. Heikkinen, M. Möttönen, K. Pulkki, O. Lassila, and A. Alanen, “Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia,” Scandinavian Journal of Immunology, vol. 53, no. 3, pp. 310–314, 2001.